Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo

Molecular and Cellular Endocrinology

Volumn 342, Issue 1-2, 2011, Pages 81-86

  Simanainen, Ulla ^a   Brogley, Michele ^b   Gao, Yan Ru ^a   Jimenez, Mark ^a   Harwood, D Tim ^a   Handelsman, David J ^a   Robins, Diane M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AR; CAG repeat; Glutamine tract; Humanized mouse model

Indexed keywords

3BETA ANDROSTANEDIOL; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; LUTEINIZING HORMONE;

AMINO TERMINAL SEQUENCE; ANDROGEN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; GENE INACTIVATION; HORMONAL REGULATION; HORMONE METABOLISM; HORMONE SENSITIVITY; IN VIVO STUDY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MOUSE; N TERMINAL GLUTAMINE TRACT; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE; SEMINAL VESICLE;

ANDROGENS; ANIMALS; CELL PROLIFERATION; DIHYDROTESTOSTERONE; GENE KNOCK-IN TECHNIQUES; HUMANS; MALE; MICE; MICE, TRANSGENIC; ORCHIECTOMY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEATS;

EID: 79960846244     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.011     Document Type: Article

References (36)

1. Albertelli M.A., Scheller A., Brogley M., Robins D.M. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol. Endocrinol. 2006, 20:1248-1260.
2. Albertelli M.A., O'Mahony O.A., Brogley M., Tosoian J., Steinkamp M., Daignault S., Wojno K., Robins D.M. Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice. Hum. Mol. Genet. 2008, 17:98-110.
3. Allan C.M., Couse J.F., Simanainen U., Spaliviero J., Jimenez M., Rodriguez K., Korach K.S., Handelsman D.J. Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion. Endocrinology 2010, 151:2800-2810.
4. Bartke A., Dalterio S. Evidence for episodic secretion of testosterone in laboratory mice. Steroids 1975, 26:749-756.
5. Beilin J., Ball E.M., Favaloro J.M., Zajac J.D. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J. Mol. Endocrinol. 2000, 25:85-96.
6. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994, 22:3181-3186.
7. Chen Y., Robles A.I., Martinez L.A., Liu F., Gimenez-Conti I.B., Conti C.J. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ. 1996, 7:1571-1578.
8. Coquelin A., Desjardins C. Luteinizing hormone and testosterone secretion in young and old male mice. Am. J. Physiol. 1982, 243:E257-E263.
9. Crabbe P., Bogaert V., De Bacquer D., Goemaere S., Zmierczak H., Kaufman J.M. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J. Clin. Endocrinol. Metab. 2007, 92:3604-3610.
10. Cunha G.R., Donjacour A.A., Cooke P.S., Mee S., Bigsby R.M., Higgins S.J., Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr. Rev. 1987, 8:338-362.
11. Cunha G.R., Ricke W., Thomson A., Marker P.C., Risbridger G., Hayward S.W., Wang Y.Z., Donjacour A.A., Kurita T. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J. Steroid Biochem. Mol. Biol. 2004, 92:221-236. (Epub 2004 December 21).
12. Harwood D.T., Handelsman D.J. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin. Chim. Acta 2009, 409:78-84.
13. Hayes F.J., DeCruz S., Seminara S.B., Boepple P.A., Crowley W.F. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J. Clin. Endocrinol. Metab. 2001, 86:53-58.
14. Hayes F.J., Pitteloud N., DeCruz S., Crowley W.F., Boepple P.A. Importance of inhibin B in the regulation of FSH secretion in the human male. J. Clin. Endocrinol. Metab. 2001, 86:5541-5546.
15. Heinlein C.A., Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 2004, 25:276-308.
16. Huhtaniemi I.T., Pye S.R., Limer K.L., Thomson W., O'Neill T.W., Platt H., Payne D., John S.L., Jiang M., Boonen S., Borghs H., Vanderschueren D., Adams J.E., Ward K.A., Bartfai G., Casanueva F., Finn J.D., Forti G., Giwercman A., Han T.S., Kula K., Lean M.E., Pendleton N., Punab M., Silman A.J., Wu F.C. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J. Clin. Endocrinol. Metab. 2009, 94:277-284.
17. Jimenez M., Spaliviero J.A., Grootenhuis A.J., Verhagen J., Allan C.M., Handelsman D.J. Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone. Biol. Reprod. 2005, 72:78-85.
18. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 2005, 26:833-876.
19. Krithivas K., Yurgalevitch S.M., Mohr B.A., Wilcox C.J., Batter S.J., Brown M., Longcope C., McKinlay J.B., Kantoff P.W. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J. Endocrinol. 1999, 162:137-142.
20. Lieberman A.P., Robins D.M. The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer. J. Alzheimers Dis. 2008, 14:247-255.
21. Lindstrom S., Ma J., Altshuler D., Giovannucci E., Riboli E., Albanes D., Allen N.E., Berndt S.I., Boeing H., Bueno-de-Mesquita H.B., Chanock S.J., Dunning A.M., Feigelson H.S., Gaziano J.M., Haiman C.A., Hayes R.B., Henderson B.E., Hunter D.J., Kaaks R., Kolonel L.N., Le Marchand L., Martinez C., Overvad K., Siddiq A., Stampfer M., Stattin P., Stram D.O., Thun M.J., Trichopoulos D., Tumino R., Virtamo J., Weinstein S.J., Yeager M., Kraft P., Freedman M.L. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J. Clin. Endocrinol. Metab. 2010, 95:E121-E127.
22. McNamara K.M., Harwood D.T., Simanainen U., Walters K.A., Jimenez M., Handelsman D.J. Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J. Steroid Biochem. Mol. Biol. 2010, 121:611-618.
23. Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M., French F.S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 1995, 16:271-321.
24. Rajender S., Singh L., Thangaraj K. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J. Androl. 2007, 9:147-179.
25. Simanainen U., Allan C.M., Lim P., McPherson S., Jimenez M., Zajac J.D., Davey R.A., Handelsman D.J. Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. Endocrinology 2007, 148:2264-2272.
26. Simanainen U., McNamara K., Gao Y.R., Handelsman D.J. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1335-E1343.
27. Singh J., O'Neill C., Handelsman D.J. Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 1995, 136:5311-5321.
28. Spearow J.L., Trost B.A. Development of a sensitive enzyme-linked immunosorbent assay for cattle, sheep, rat, and mouse luteinizing hormone. Biol. Reprod. 1987, 37:595-605.
29. Stanworth R.D., Kapoor D., Channer K.S., Jones T.H. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur. J. Endocrinol. 2008, 159:739-746.
30. Thomas P.S., Fraley G.S., Damian V., Woodke L.B., Zapata F., Sopher B.L., Plymate S.R., La Spada A.R. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2006, 15:2225-2238.
31. Tut T.G., Ghadessy F.J., Trifiro M.A., Pinsky L., Yong E.L. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocrinol. Metab. 1997, 82:3777-3782.
32. Van Pottelbergh I., Lumbroso S., Goemaere S., Sultan C., Kaufman J.M. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin. Endocrinol. (Oxf.) 2001, 55:659-666.
33. Walsh S., Zmuda J.M., Cauley J.A., Shea P.R., Metter E.J., Hurley B.F., Ferrell R.E., Roth S.M. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J. Appl. Physiol. 2005, 98:132-137.
34. Wu C.T., Altuwaijri S., Ricke W.A., Huang S.P., Yeh S., Zhang C., Niu Y., Tsai M.Y., Chang C. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc. Natl. Acad. Sci. USA 2007, 104:12679-12684.
35. Zitzmann M., Brune M., Kornmann B., Gromoll J., von Eckardstein S., von Eckardstein A., Nieschlag E. The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J. Clin. Endocrinol. Metab. 2001, 86:4867-4873.
36. Zitzmann M., Depenbusch M., Gromoll J., Nieschlag E. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J. Clin. Endocrinol. Metab. 2003, 88:2049-2054.